+ All Categories
Home > Documents > Surgical Treatment for Type 2 Diabetes...– American Diabetes Association-Standards of Care 2017...

Surgical Treatment for Type 2 Diabetes...– American Diabetes Association-Standards of Care 2017...

Date post: 04-Oct-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
2
How Does Surgery Improve Diabetes Metabolic surgery changes various mechanisms of GI physiology involved in metabolic regulation (3,4) Metabolic surgery is now a recommended treatment options for Type 2 diabetes among certain patients also suffering from obesity – American Diabetes Association-Standards of Care 2017 (1) Indications for Surgical Treatment There is now sufficient clinical and mechanistic evidence to support inclusion of metabolic surgery among antidiabetes interventions for people with Type 2 diabetes (T2D) and obesity.” DSS-11 (2) • “Metabolic surgery should be a recpmmended option to treat T2D in appropriate surgical candidates with class III obesity (BMI 40 kg/m2, regardless of the level of glycemic control or complexity of glucose-lowering regimens, as well as in patients with class II obesity (BMI 35.0- 39.9kg/m2) with inadequately controlled hyperglycemia despite lifestyle and optimal medical therapy.” DSS-II (2) • “Metabolic surgery should also be considered to be an option to treat T2D in patients with class 1 obesity (BMI 30.0-39.9 kg/m2) and inadequately controlled hyperglycemia despite optional medical treatment by either oral or injectable medications (including insulin).” DSS-II (2) • “All BMI thresholds should be reconsidered depending on the ancestry of the patient. For example, patients of Asian descent, the MBI values above should be reduced by 2.5 kg/ m2.” DSS-II (2) Algorithm for Patients with Type 2 Diabetes Non-Obese BMI < 30kg/m2 or 27.5 for Asians Obese BMI 30kg/m2 or 27.5 for Asians Class I Class II Class III Optimal lifestyle & Medical Rx (incl injectable meds & insulin) Optimal lifestyle & Medical Rx Expedited Assessment for Metabolic Surgery Good Glycemia Control Poor Glycemia Control Good Glycemia Control Poor Glycemia Control Nonsurgical Treatment Consider Metabolic Surgery Recommend Metabolic Surgery Class I BMI 30-34.9 kg/m 2 or 27.5-32.4 for Asians Class II BMI 35-39.9 kg/m 2 or 32.5-37.4 for Asians Class III BMI 40 kg/m 2 or 37.4 for Asians Surgical Treatment for Type 2 Diabetes GUT HORMONES GUT MICROBIOTA BILE ACIDS NUTRIENT SENSING Increased insulin secretion Increased insulin sensitivity Increased satiation & weight loss METABOLIC SURGERY
Transcript
Page 1: Surgical Treatment for Type 2 Diabetes...– American Diabetes Association-Standards of Care 2017 (1) Indications for Surgical Treatment. There is now sufficient clinical and mechanistic

How Does Surgery Improve Diabetes

Metabolic surgery changes various

mechanisms of GI physiology involved in

metabolic regulation (3,4)

Metabolic surgery is now a recommended treatment options for Type 2 diabetes among certain patients also suffering from obesity

– American Diabetes Association-Standards of Care 2017 (1)

Indications for Surgical Treatment

There is now sufficient clinical and mechanistic evidence to support

inclusion of metabolic surgery among antidiabetes interventions for

people with Type 2 diabetes (T2D) and obesity.” DSS-11 (2)

• “Metabolic surgery should be arecpmmended option to treat T2D in appropriate surgical candidates with class III obesity (BMI ≥ 40 kg/m2, regardless of

the level of glycemic control or complexity of glucose-lowering regimens, as well as in patients with class II obesity (BMI 35.0- 39.9kg/m2) with inadequately controlled hyperglycemia despite lifestyle and optimal medical therapy.” DSS-II (2)

• “Metabolic surgery should also be consideredto be an option to treat T2D in patients with class 1 obesity (BMI 30.0-39.9 kg/m2) and inadequately controlled hyperglycemia despite optional medical treatment by either oral or injectable medications (including insulin).” DSS-II (2)

• “All BMI thresholds should be reconsidereddepending on the ancestry of the patient. For example, patients of Asian descent, the MBI values above should be reduced by 2.5 kg/m2.” DSS-II (2)

Algorithm for Patients with Type 2 Diabetes

Non-ObeseBMI < 30kg/m2 or

27.5 for Asians

ObeseBMI ≥ 30kg/m2 or 27.5 for Asians

Class I Class II Class III

Optimal lifestyle & Medical Rx (incl injectable meds & insulin)

Optimal lifestyle & Medical Rx

Expedited Assessment for Metabolic Surgery

thumbsup Good

Glycemia Control

thumbsdownPoor

Glycemia Control

thumbsup Good

Glycemia Control

thumbsdownPoor

Glycemia Control

Nonsurgical Treatment

Consider Metabolic Surgery

Recommend Metabolic Surgery

Class I BMI ≥ 30-34.9 kg/m2 or 27.5-32.4 for Asians

Class II BMI ≥ 35-39.9 kg/m2 or 32.5-37.4 for Asians

Class III BMI ≥ 40 kg/m2 or 37.4 for Asians

Surgical Treatment for Type 2 Diabetes

GUT HORMONES GUT MICROBIOTA

BILE ACIDS NUTRIENT SENSING

Increased insulin secretion

Increased insulin sensitivity

Increased satiation & weight loss

up

up

up

METABOLIC SURGERY

Page 2: Surgical Treatment for Type 2 Diabetes...– American Diabetes Association-Standards of Care 2017 (1) Indications for Surgical Treatment. There is now sufficient clinical and mechanistic

Clinical Evidence (2,5)

Observations that Type 2 diabetes (T2D) can be improved

or even resolved by surgical operation have been reported

for almost a century. Since the 2000s, experimental

evidence that changes in GI anatomy can directly

influence glucose homeostasis provided a mechanistic

rationale for the use of surgery as an intentional treatment

of diabetes. DSS-I and DSS-II assessed clinical evidence,

including numerous Randomized Clinical Trials (RCTs)

performed over the last decade, leading to current

guidelines. Eleven randomized trials (RCTs – Level 1 evidence) as well

as large, long-term case controlled studies (Level 2

evidence) comparing surgery in overweight/obese people

with Type 2 diabetes show that metabolic surgery results in:

Chance of Disease Remission: A substantial proportion

of patients (between 30% and 60%, depending on the

procedure) experience durable (≥5 year) normalization

of blood sugar levels without the need for ongoing

pharmacologic treatment (disease remission)

Cost Effectiveness: Economic analyses have also

shown that surgical treatment for diabetes are cost-

effective. Cost per quality adjusted life-year (QALY) is

approximately $3,200-$6,500, well below $50,000/QALY

(which is deemed appropriate for coverage).

Study (operations)

Total

Wentworth 2014

Liang 2013

Parikh 2014

Ikramuddin 2013

Ikramuddin 2015

Courcoulas 2014

Courcoulas 2015

FavorsMeds & Lifestyle

.001 .1 1 10 1000

FavorsSurgery

Halperin 2014

Ding 2015

Dixon 2008

Schauer 2012

Schauer 2014

Cummings 2015

Mingrone 2012

Mingrone 2015

Peto odds ratio

RYGB LAGB VSG BPD

Randomized Clinical Trials - Level 1 Evidence Surgery vs Lifestyle & Pharmocotherapy

�� ��

BM

I >

35

BM

I ≤

35

Based on Rubino F. et al. Diabetes Care 2016; 39, 861-877

Asc

en

din

g M

ean

Base

line B

MI

Reduction of CVD & Mortality Risk

40

30

20

10

0

0 2 4 6 8 10 12

YEARS AFTER SURGERY

% M

OR

TA

LIT

Y

Based on Arterbum D. et al; JAMA. 2015; 313 (1); 62-70

Controlpatients

Surgicalpatients

Reduction of Medication Usage

100

80

60

40

20

0

Start ofClinical Trial

2 years later 5 years later

% P

AT

IEN

TS

US

ING

IN

SU

LIN

OR

OT

HE

R I

NJE

CT

AB

LE

ME

DIC

AT

ION

Based on Migrone G. et al; Lancet 2015; 386 (9997): 964-973

Surgery

No SurgeryPatients who do not have surgery are more likely to

increase their use of injectables over time

0

10

8

6

51 3 6 9 12

MONTHS

Non-Diabetic

Diabetic

HB

A1C

Major Improvement of Glycemia

References

(1) ADA Standards of Medical Care in Diabetes 2017 Diabetes Care; Jan. 2017; vol. 40 Issue Suppl. 1

(2) Rubine F. et al. Diabetes Care Diabetes Care 2016; Jun. 39 (6): 861-877

(3) Rubine F. Nature 2016; 533(7604)459-61

(4) Evers SS et al. Annu Rev Physiol. 2017 Feb 10; 79313-334

(5) Cummings DE and Cohen R. Diabetes Care 2016 Jun; 39 (6): 924-933

• Greater improvement of glycemiccontrol (Level 1 evidence)

• Reduction of medication usage(Level 1 evidence)

• Reduction of cardiovascular disease(CVD) risk (Level 1 evidence)

• Reduction of heat attacks, strokes,cancer and overall mortality(Level 2 evidence)

• Greater weight loss (Level 1 evidence)

• Better quality of life (Level 1evidence)

Fresno Heart & Surgical Hospital15 E. Audubon DriveFresno, CA 93720(866) 433-8558

Metabolic & Bariatric Surgery ProgramFresnoBariatrics.org


Recommended